## Abstract Recent studies have linked dopamine agonist (DA) usage with the development of impulse control disorders (ICDs) in Parkinson's disease (PD). Little is known about optimal management strategies or the longβterm outcomes of affected patients. To report on the clinical interventions and lo
Long-term follow-up of early dopa treatment in Parkinson's disease
β Scribed by Dr. Charles H. Markham; Shirley G. Diamond
- Publisher
- John Wiley and Sons
- Year
- 1986
- Tongue
- English
- Weight
- 725 KB
- Volume
- 19
- Category
- Article
- ISSN
- 0364-5134
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract The purpose of this study to compare the longβterm clinical outcome of early versus delayed rasagiline treatment in early Parkinson's disease (PD). Subjects (N = 404) were randomly assigned to initial treatment with rasagiline (earlyβstart group) or placebo for 6 months followed by rasa
To assess the long-term follow-up of the globus pallidus internus (GPi) stimulation, six patients were evaluated every year by using the Unified Parkinson's Disease Rating Scale (UPDRS). Three years postoperatively, GPi stimulation led to a significant improvement of dyskinesia severity (50%, P = 0.
Continuous subcutaneous infusion of apomorphine is now increasingly recognized as an effective treatment for refractory off periods and peak-dose dyskinesias in Parkinson's disease. We have reviewed our experience with apomorphine infusions, after a strategy decision in 1995 based on emerging precli
We report on the long-term clinical course of 4 boys with Menkes disease, treated from early infancy with parenteral copperhistidine, with follow-up over 10-20 years. Three of the 4 had male relatives with a severe clinical course compatible with classical Menkes disease. As a consequence of early t